WuXi PharmaTech. received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients.
Dr. Alfred Hackenberger, President of the Specialty Chemicals Research Division at BASF, said: We had been looking for a good CRO collaboration partner for years, and today I think we have found one, a top-notch partner. And I know that WuXi will continue to provide the same excellent service in the future.
We are pleased to receive this award by BASF in recognition of the efforts of WuXi\'s talented team. We will continue to focus on customer service to earn the trust and support of our partners, said Dr. Ge Li, Chairman and CEO of WuXi AppTec. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Its services are designed to help its global partners to improve the success of research and shorten the time of development cost effectively in discovering and developing drugs and medical devices.